These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21360595)

  • 21. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys.
    Banks ML; Sprague JE; Kisor DF; Czoty PW; Nichols DE; Nader MA
    Drug Metab Dispos; 2007 Oct; 35(10):1840-5. PubMed ID: 17640955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants.
    Antolino-Lobo I; Meulenbelt J; Molendijk J; Nijmeijer SM; Scherpenisse P; van den Berg M; van Duursen MB
    Toxicology; 2011 Nov; 289(2-3):175-84. PubMed ID: 21871945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.
    Hashimoto K; Maeda H; Goromaru T
    Eur J Pharmacol; 1992 Sep; 228(2-3):171-4. PubMed ID: 1280228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.
    Bai F; Jones DC; Lau SS; Monks TJ
    Chem Res Toxicol; 2001 Jul; 14(7):863-70. PubMed ID: 11453733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K; Maeda H; Goromaru T
    Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.
    Barbosa DJ; Capela JP; Silva R; Ferreira LM; Branco PS; Fernandes E; Bastos ML; Carvalho F
    Arch Toxicol; 2014 Feb; 88(2):515-31. PubMed ID: 24177245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.
    Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
    Izco M; Orio L; O'Shea E; Colado MI
    Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
    Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
    Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G; Yeh SY; De Souza EB
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M; Stone DM; Bush LG; Hanson GR; Gibb JW
    Eur J Pharmacol; 1989 Feb; 161(2-3):181-8. PubMed ID: 2470597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
    Paris JM; Cunningham KA
    Brain Res Bull; 1992 Jan; 28(1):115-9. PubMed ID: 1347247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.